Key result
Dilated cardiomyopathy and myocarditis were associated with myocardial DNA strand breaks in 33.3% (3/9) and 100% (4/4) of patients respectively, compared to 0% (0/5) in controls.
Why the study?
Are DNA strand breaks present in the myocardium of patients with dilated cardiomyopathy and myocarditis compared to controls?
Observational (n=18)
Are DNA strand breaks present in the myocardium of patients with dilated cardiomyopathy and myocarditis compared to controls?
DNA strand breaks are present in the cardiomyocytes of some patients with dilated cardiomyopathy and correlate with increased interstitial fibrosis, suggesting a potential mechanism for progressive myocardial damage.
BACKGROUND: Progressive damage of cardiomyocytes with interstitial and replacement fibrosis accompanied by less inflammatory cell infiltration is observed in patients with dilated cardiomyopathy (DCM), suggesting some other mechanisms rather than necrotic cell death. HYPOTHESIS: The aim of this study was to assess the possible involvement of apoptotic process in the pathogenesis of DCM and myocarditis. METHODS: Endomyocardial biopsy was performed in patients with DCM (n = 9), myocarditis (n = 4), or atypical chest pain syndrome (as controls; n = 5). The TUNEL method was used for in situ detection of oligonucleosomal DNA strand breaks. RESULTS: The TUNEL-positive cells were observed in three of nine patients with DCM and in all four with myocarditis, but in none of the controls. The TUNEL-positive nuclei were observed exclusively in cardiomyocytes in DCM, whereas in myocarditis they were detected mainly in interstitial cells and in a few myocytes. In DCM, interstitial fibrosis was greater in the TUNEL-positive than in TUNEL-negative patients (p < 0.05). In either DCM or myocarditis, electron microscopic examination could not reveal morphologic features of apoptosis of cardiomyocytes. CONCLUSION: The DNA strand breaks were detected in cardiomyocytes in patients with DCM and mainly in interstitial cells in myocarditis. It is possible that the DNA strand breaks can be involved in mechanisms of progressive loss of functional cardiac units in these myocardial diseases.
No takes yet. Share an insight, caveat, or question.
Seki et al. (1998) conducted an observational in Dilated cardiomyopathy and myocarditis (n=18). Dilated cardiomyopathy and myocarditis vs. Atypical chest pain syndrome (controls) was evaluated on In situ detection of oligonucleosomal DNA strand breaks (TUNEL-positive cells). Dilated cardiomyopathy and myocarditis were associated with myocardial DNA strand breaks in 33.3% (3/9) and 100% (4/4) of patients respectively, compared to 0% (0/5) in controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on MyocarditisMore from Clinical Cardiology